Product: ILK Antibody
Catalog: BF0030
Description: Mouse monoclonal antibody to ILK
Application: WB IHC ELISA FACS
Reactivity: Human, Mouse, Monkey
Mol.Wt.: 51.4kDa; 51kD(Calculated).
Uniprot: Q13418
RRID: AB_2834054

View similar products>>

   Size Price Inventory
 50ul $250 In stock
 100ul $350 In stock
 200ul $450 In stock

Lead Time: Same day delivery

For pricing and ordering contact:
Local distributors

Product Info

ELISA 1:10000, WB 1:500-1:2000, IHC 1:200-1:1000, FCM 1:200-1:400
*The optimal dilutions should be determined by the end user.

WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.

Monoclonal [AFB2032]
ILK antibody detects endogenous levels of total ILK.
Cite Format: Affinity Biosciences Cat# BF0030, RRID:AB_2834054.
Mouse IgG1 in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.


59 kDa serine/threonine protein kinase; 59 kDa serine/threonine-protein kinase; DKFZp686F1765; Epididymis secretory protein Li 28; HEL S 28; ILK 1; ILK 2; ILK; ILK-1; ILK-2; ILK_HUMAN; ILK1; ILK2; Integrin linked kinase 2; Integrin linked Kinase; Integrin linked protein kinase; Integrin-linked protein kinase; p59; p59ILK;



Purified recombinant fragment of human ILK expressed in E. Coli.


Highly expressed in heart followed by skeletal muscle, pancreas and kidney. Weakly expressed in placenta, lung and liver.

influences intracellular and extracellular functions, and appears to require interaction of integrin cytoplasmic domains with cellular proteins. Integrin-linked kinase (ILK), interacts with the cytoplasmic domain of beta-1 integrin.

PTMs - Q13418 As Substrate

Site PTM Type Enzyme
M1 Acetylation
T69 Phosphorylation
S76 Phosphorylation
K85 Ubiquitination
K139 Ubiquitination
K154 Ubiquitination
K165 Ubiquitination
K170 Methylation
K170 Ubiquitination
T172 Phosphorylation
T173 Phosphorylation P17252 (PRKCA) , Q13153 (PAK1)
T181 Phosphorylation P17252 (PRKCA)
K184 Ubiquitination
S186 Phosphorylation
K191 Sumoylation
K191 Ubiquitination
K198 Ubiquitination
S204 Phosphorylation
K209 Ubiquitination
K220 Ubiquitination
S232 Phosphorylation
S246 Phosphorylation Q13153 (PAK1)
K341 Ubiquitination
S343 Phosphorylation Q13418 (ILK)
C346 S-Nitrosylation
K423 Ubiquitination
K426 Acetylation
K426 Ubiquitination
K435 Ubiquitination
K438 Ubiquitination
K448 Ubiquitination

PTMs - Q13418 As Enzyme

Substrate Site Source
E9PAV3 (NACA) S1906 Uniprot
O14950 (MYL12B) T19 Uniprot
O14950 (MYL12B) S20 Uniprot
O14974-1 (PPP1R12A) T696 Uniprot
O14974 (PPP1R12A) T710 Uniprot
P23528 (CFL1) S3 Uniprot
P31749 (AKT1) S473 Uniprot
Q13418-1 (ILK) S343 Uniprot
Q13765 (NACA) S43 Uniprot
Q8TAE6 (PPP1R14C) T73 Uniprot
Q96A00 (PPP1R14A) T38 Uniprot
Q96C90 (PPP1R14B) T57 Uniprot

Research Backgrounds


Receptor-proximal protein kinase regulating integrin-mediated signal transduction. May act as a mediator of inside-out integrin signaling. Focal adhesion protein part of the complex ILK-PINCH. This complex is considered to be one of the convergence points of integrin- and growth factor-signaling pathway. Could be implicated in mediating cell architecture, adhesion to integrin substrates and anchorage-dependent growth in epithelial cells. Phosphorylates beta-1 and beta-3 integrin subunit on serine and threonine residues, but also AKT1 and GSK3B.


Autophosphorylated on serine residues.

Subcellular Location:

Cell junction>Focal adhesion. Cell membrane>Peripheral membrane protein>Cytoplasmic side. Cell projection>Lamellipodium. Cytoplasm>Myofibril>Sarcomere.

Extracellular region or secreted Cytosol Plasma membrane Cytoskeleton Lysosome Endosome Peroxisome ER Golgi apparatus Nucleus Mitochondrion Manual annotation Automatic computational assertionSubcellular location
Tissue Specificity:

Highly expressed in heart followed by skeletal muscle, pancreas and kidney. Weakly expressed in placenta, lung and liver.

Subunit Structure:

Interacts with FERMT2 (By similarity). Interacts with the cytoplasmic domain of ITGB1. Could also interact with integrin ITGB2, ITGB3 and/or ITGB5. Interacts (via ANK repeats) with LIMS1 and LIMS2. Interacts with PARVA and PARVB; these compete for the same binding site. Interacts probably also with TGFB1I1. Interacts (via ANK repeats) with EPHA1 (via SAM domain); stimulated by EFNA1 but independent of the kinase activity of EPHA1. Interacts with LIMD2; leading to activate the protein kinase activity.


A PH-like domain is involved in phosphatidylinositol phosphate binding.

Belongs to the protein kinase superfamily. TKL Ser/Thr protein kinase family.

Research Fields

· Cellular Processes > Cellular community - eukaryotes > Focal adhesion.   (View pathway)

· Human Diseases > Infectious diseases: Bacterial > Bacterial invasion of epithelial cells.

· Human Diseases > Cancers: Specific types > Endometrial cancer.   (View pathway)

· Organismal Systems > Endocrine system > PPAR signaling pathway.

· Organismal Systems > Development > Axon guidance.   (View pathway)

Restrictive clause


Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.

For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.